Literature DB >> 2875784

Paraganglioma of the cauda equina region. Clinicopathologic study of 31 cases with special reference to immunocytology and ultrastructure.

P R Sonneland, B W Scheithauer, J LeChago, B G Crawford, B M Onofrio.   

Abstract

Thirty-one paragangliomas of the cauda equina region were studied (18 men and 13 women, ages 30-71 years [mean, 51 years]). Symptoms (1 day to 15 years in duration; mean, 48 months) included low back pain (87%), sensory/motor deficits (35%), urinary/fecal incontinence (13%), and paraplegia (6%). All patients studied had some myelographic block. Cerebrospinal fluid protein level ranged from 56 to 7000 mg/dl (mean, 1109 mg/dl). Most tumors were limited to the filum terminale, although one also involved the conus medullaris and two clearly arose from a caudal nerve root. All but one were entirely intradural. The tumor was totally excised in 26 cases; these patients remain disease-free. Of three patients whose tumors were excised subtotally, two received radiotherapy; the one non-radiated patient died of tumor-related complications. No autopsy was performed. One partially encapsulated tumor that had been subjected to biopsy and irradiation presented 1 year later with osseous invasion and retroperitoneal extension; 20 years after subtotal excision, this patient is alive but paraplegic. Morphologically, all tumors resembled paraganglioma at other sites. Cytologic atypia and mitotic activity generally were absent to mild. Fourteen (45%) cases showed ganglionic differentiation. All tumors tested were immunoreactive for neuron-specific enolase and neurofilament protein, and most showed somatostatin or serotonin reactivity. S-100 protein immunoreactivity was noted in sustentacular cells and, to a lesser extent, within chief cells and neurons. The authors conclude that paragangliomas are largely benign and encapsulated and respond to simple resection. When surgically feasible, gross total removal should be the goal of surgery. When subtotal resection is necessary or when local invasion leaves a question as to completeness of tumor removal, irradiation seems mandatory although far from guaranteeing prevention of recurrence. Biopsy alone is undesirable.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875784     DOI: 10.1002/1097-0142(19861015)58:8<1720::aid-cncr2820580824>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

Review 1.  Familial malignant retroperitoneal paraganglioma.

Authors:  J P Sebastian; S E Williams; M Wells; M D Peake
Journal:  Postgrad Med J       Date:  1989-10       Impact factor: 2.401

2.  Clinical characteristics and surgical outcomes of primary spinal paragangliomas.

Authors:  Chenlong Yang; Guang Li; Jingyi Fang; Liang Wu; Tao Yang; Xiaofeng Deng; Yulun Xu
Journal:  J Neurooncol       Date:  2015-02-27       Impact factor: 4.130

3.  Freiburg neuropathology case conference: an intradural mass lesion of the lumbar spine.

Authors:  C A Taschner; S Brendecke; T Freiman; I Mader; M Prinz
Journal:  Clin Neuroradiol       Date:  2012-06       Impact factor: 3.649

4.  Paraganglioma of the filum terminale: case report.

Authors:  Alessandro Landi; Roberto Tarantino; Nicola Marotta; Pierluigi Rocco; Manila Antonelli; Maurizio Salvati; Roberto Delfini
Journal:  World J Surg Oncol       Date:  2009-12-11       Impact factor: 2.754

5.  Non-functional malignant paraganglioma of the stomach.

Authors:  C Schmid; A Beham; P Steindorfer; L Auböck; F Waltner
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

6.  Paraganglioma of the cauda equina.

Authors:  J W Ironside
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

Review 7.  Cauda equina paraganglioma: a review.

Authors:  George C Miliaras; Athanassios P Kyritsis; Konstantinos S Polyzoidis
Journal:  J Neurooncol       Date:  2003-11       Impact factor: 4.130

Review 8.  [Tumors of the adrenal medulla and the paraganglia].

Authors:  G Klöppel
Journal:  Pathologe       Date:  2003-05-29       Impact factor: 1.011

Review 9.  Orbital paraganglioma: case report and review of the literature.

Authors:  M M Bednar; T D Trainer; P A Aitken; R Grenko; R Dorwart; J Duckworth; C E Gross; W W Pendlebury
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

10.  Growth factors and cytokines in paragangliomas and pheochromocytomas, with special reference to sustentacular cells.

Authors:  George Kontogeorgos; Bernd W Scheithauer; Kalman Kovacs; Eva Horvath; Sclomo Melmed
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.